I would have thought that the major issue is recovery. We can bash the topic of why until we froth at the mouth but without recovery at or near DFS level the share price will struggle.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come